COMBINATIONS OF EGFR INHIBITORS AND ANTI-HUMAN VEGFR-2 ANTIBODIES
- 专利权人:
- Medimmune Limited;Eli Lilly and Company
- 发明人:
- Bo Hua CHAO,Sang Min LEE
- 申请号：
- US16633230
- 公开号：
- US20200155551A1
- 申请日:
- 2018.08.20
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention relates to a combination of anti-human VEGFR-2 antibodies and human EGFR tyrosine kinase inhibitors for the treatment of T790M-positive EGFR-mutant non-small cell lung cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- HYBRID CHIMERA POLYPEPTIDES AS DUAL INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR AND PLATELET-DERIVED GROWTH FACTOR RECEPTOR
- INHIBITORS OF VEGF RECEPTOR AND HGF RECEPTOR SIGNALING
- Selected Inhibitors of Protein Tyrosine Kinase Activity
- מעכבי vegfr–3 להכנת תרופות לטיפול בקרצינומה של הכבד
- USE OF PD-1 ANTIBODY COMBINED WITH VEGF LIGAND OR VEGF RECEPTOR INHIBITOR IN PREPARING DRUG FOR TREATING TUMOR
